Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Myasthenia gravis: past, present, and future Conti-Fine BM; Milani M; Kaminski HJJ Clin Invest 2006[Nov]; 116 (11): 2843-54Myasthenia gravis (MG) is an autoimmune syndrome caused by the failure of neuromuscular transmission, which results from the binding of autoantibodies to proteins involved in signaling at the neuromuscular junction (NMJ). These proteins include the nicotinic AChR or, less frequently, a muscle-specific tyrosine kinase (MuSK) involved in AChR clustering. Much is known about the mechanisms that maintain self tolerance and modulate anti-AChR Ab synthesis, AChR clustering, and AChR function as well as those that cause neuromuscular transmission failure upon Ab binding. This insight has led to the development of improved diagnostic methods and to the design of specific immunosuppressive or immunomodulatory treatments.|Animals[MESH]|History, 17th Century[MESH]|History, 19th Century[MESH]|History, 20th Century[MESH]|History, 21st Century[MESH]|Humans[MESH]|Immunosuppressive Agents/therapeutic use[MESH]|Lymphocytes/immunology/metabolism[MESH]|Myasthenia Gravis/diagnosis/*drug therapy/history/*immunology[MESH]|Neuromuscular Junction/immunology/metabolism/pathology[MESH]|Receptors, Cholinergic/immunology/metabolism[MESH] |